- Home
- CNM vs BAX Comparison
CNM vs BAX Comparison
Compare CNM & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- BAX
- Stock Information
- Founded
- CNM 1996
- BAX 1931
- Country
- CNM United States
- BAX United States
- Employees
- CNM N/A
- BAX N/A
- Industry
- CNM Durable Goods
- BAX Medical/Dental Instruments
- Sector
- CNM Consumer Discretionary
- BAX Health Care
- Exchange
- CNM Nasdaq
- BAX Nasdaq
- Market Cap
- CNM 9.9B
- BAX 9.2B
- IPO Year
- CNM 2021
- BAX N/A
- Fundamental
- Price
- CNM $50.34
- BAX $18.26
- Analyst Decision
- CNM Buy
- BAX Hold
- Analyst Count
- CNM 11
- BAX 10
- Target Price
- CNM $60.64
- BAX $27.00
- AVG Volume (30 Days)
- CNM 1.9M
- BAX 8.2M
- Earning Date
- CNM 12-02-2025
- BAX 10-30-2025
- Dividend Yield
- CNM N/A
- BAX 3.73%
- EPS Growth
- CNM 7.24
- BAX N/A
- EPS
- CNM 2.25
- BAX N/A
- Revenue
- CNM $7,740,000,000.00
- BAX $11,023,000,000.00
- Revenue This Year
- CNM $4.45
- BAX $5.72
- Revenue Next Year
- CNM $4.43
- BAX $2.52
- P/E Ratio
- CNM $22.50
- BAX N/A
- Revenue Growth
- CNM 11.02
- BAX 3.90
- 52 Week Low
- CNM $41.64
- BAX $17.47
- 52 Week High
- CNM $67.18
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- CNM 37.85
- BAX 27.44
- Support Level
- CNM $49.97
- BAX $17.57
- Resistance Level
- CNM $51.56
- BAX $18.16
- Average True Range (ATR)
- CNM 1.44
- BAX 0.55
- MACD
- CNM -0.10
- BAX -0.29
- Stochastic Oscillator
- CNM 6.22
- BAX 13.61
About CNM Core & Main Inc.
Core & Main is a leading specialty distributor with a focus on water, wastewater, storm drainage, and fire protection products. The company provides solutions to municipalities, private water companies, and professional contractors across municipal, nonresidential, and residential end markets. The company's specialty products and services are used in the maintenance, repair, replacement, and construction of water and fire protection infrastructure.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.